Rasheed Adebayo Gbadegesin

Rasheed Adebayo Gbadegesin

Professor of Pediatrics

Molecular genetics of glomerular disease
Genetic risk factors for childhood onset idiopathic nephrotic syndrome

Appointments and Affiliations

  • Professor of Pediatrics
  • Professor in Medicine
  • Affiliate of Duke Molecular Physiology Institute

Contact Information

  • Office Location: T0909-C Children's Hlth Ctr, Durham, NC 27710
  • Office Phone: (919) 684-4246
  • Email Address: rasheed.gbadegesin@duke.edu

Education

  • University of Michigan, Ann Arbor, 2007
  • New York Presbyterian Hospital, 2004
  • University of Ibadan, College of Medicine (Nigeria), 1995
  • University of Ibadan, College of Medicine (Nigeria), 1989
  • University of Ibadan, College of Medicine (Nigeria), 1988
  • M.B.B.S. University of Ibadan, College of Medicine (Nigeria), 1987

Courses Taught

  • CRP 270-BST: Research BST
  • HGP 301B: Research in HGP

Representative Publications

  • Esezobor, C; Ademola, AD; Adetunji, AE; Anigilaje, EA; Batte, A; Jiya-Bello, FN; Furia, FF; Muoneke, U; McCulloch, M; Nourse, P; Obiagwu, P; Odetunde, O; Okyere, P; Solarin, A; Tannor, EK; Noone, D; Gbadegesin, R; Parekh, RS; Human Hereditary and Health in Africa Kidney Disease Research Network,, Management of idiopathic childhood nephrotic syndrome in sub-Saharan Africa: Ibadan consensus statement., Kidney Int, vol 99 no. 1 (2021), pp. 59-67 [10.1016/j.kint.2020.07.045] [abs].
  • Jia, X; Yamamura, T; Gbadegesin, R; McNulty, MT; Song, K; Nagano, C; Hitomi, Y; Lee, D; Aiba, Y; Khor, S-S; Ueno, K; Kawai, Y; Nagasaki, M; Noiri, E; Horinouchi, T; Kaito, H; Hamada, R; Okamoto, T; Kamei, K; Kaku, Y; Fujimaru, R; Tanaka, R; Shima, Y; Research Consortium on Genetics of Childhood Idiopathic Nephrotic Syndrome in Japan, ; Baek, J; Kang, HG; Ha, I-S; Han, KH; Yang, EM; Korean Consortium of Hereditary Renal Diseases in Children, ; Abeyagunawardena, A; Lane, B; Chryst-Stangl, M; Esezobor, C; Solarin, A; Midwest Pediatric Nephrology Consortium (Genetics of Nephrotic Syndrome Study Group), ; Dossier, C; Deschênes, G; NEPHROVIR, ; Vivarelli, M; Debiec, H; Ishikura, K; Matsuo, M; Nozu, K; Ronco, P; Cheong, HI; Sampson, MG; Tokunaga, K; Iijima, K, Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome., Kidney Int, vol 98 no. 5 (2020), pp. 1308-1322 [10.1016/j.kint.2020.05.029] [abs].
  • Murphy, SL; Mahan, JD; Troost, JP; Srivastava, T; Kogon, AJ; Cai, Y; Davis, TK; Fernandez, H; Fornoni, A; Gbadegesin, RA; Herreshoff, E; Canetta, PA; Nachman, PH; Reeve, BB; Selewski, DT; Sethna, CB; Wang, C-S; Bartosh, SM; Gipson, DS; Tuttle, KR; CureGN Consortium,, Longitudinal Changes in Health-Related Quality of Life in Primary Glomerular Disease: Results From the CureGN Study., Kidney International Reports, vol 5 no. 10 (2020), pp. 1679-1689 [10.1016/j.ekir.2020.06.041] [abs].
  • Hanson, CS; Craig, JC; Logeman, C; Sinha, A; Dart, A; Eddy, AA; Guha, C; Gipson, DS; Bockenhauer, D; Yap, H-K; Groothoff, J; Zappitelli, M; Webb, NJA; Alexander, SI; Furth, SL; Samuel, S; Neu, A; Viecelli, AK; Ju, A; Sharma, A; Au, EH; Desmond, H; Shen, JI; Manera, KE; Azukaitis, K; Dunn, L; Carter, SA; Gutman, T; Cho, Y; Walker, A; Francis, A; Sanchez-Kazi, C; Kausman, J; Pearl, M; Benador, N; Sahney, S; Tong, A; SONG-Kids consensus workshops investigators,, Establishing core outcome domains in pediatric kidney disease: report of the Standardized Outcomes in Nephrology-Children and Adolescents (SONG-KIDS) consensus workshops., Kidney Int, vol 98 no. 3 (2020), pp. 553-565 [10.1016/j.kint.2020.05.054] [abs].
  • Delbarba, E; Marasa, M; Canetta, PA; Piva, SE; Chatterjee, D; Kil, BH; Mu, X; Gibson, KL; Hladunewich, MA; Hogan, JJ; Julian, BA; Kidd, JM; Laurin, LP; Nachman, PH; Rheault, MN; Rizk, DV; Sanghani, NS; Trachtman, H; Wenderfer, SE; Gharavi, AG; Bomback, AS; Ahn, W; Appel, GB; Babayev, R; Batal, I; Brown, E; Campenot, ES; Canetta, P; Chan, B; D'Agati, VD; Fernandez, H; Foroncewicz, B; Ghiggeri, GM; Hines, WH; Jain, NG; Kiryluk, K; Lau, WL; Lin, F; Lugani, F; Markowitz, G; Mohan, S; Mucha, K; Nickolas, TL; Piva, S; Radhakrishnan, J; Rao, MK; Sanna-Cherchi, S; Santoriello, D; Stokes, MB; Yu, N; Valeri, AM; Zviti, R; Greenbaum, LA; Smoyer, WE; Al-Uzri, A; Ashoor, I; Aviles, D; Baracco, R; Barcia, J; Bartosh, S; Belsha, C; Bowers, C; Braun, MC; Chishti, A; Claes, D; Cramer, C; Davis, K; Erkan, E; Feig, D; Freundlich, M; Gbadegesin, R; Hanna, M; Hidalgo, G; Hunley, TE; Jain, A; Kallash, M; Khalid, M; Klein, JB; Lane, JC; Mahan, J; Mathews, N; Nester, C; Pan, C; Patterson, L; Patel, H; Revell, A; Silva, C; Sreedharan, R; Srivastava, T; Steinke, J; Twombley, K; Vasylyeva, TL; Weaver, DJ; Wong, CS; Almaani, S; Ayoub, I; Budisavljevic, M; Derebail, V; Fatima, H; Falk, R, Persistent Disease Activity in Patients With Long-Standing Glomerular Disease, Kidney International Reports, vol 5 no. 6 (2020), pp. 860-871 [10.1016/j.ekir.2020.03.017] [abs].